Holistic and network analysis of meningioma pathogenesis and malignancy

BioFactors

Volumn 28, Issue 3-4, 2006, Pages 203-219

  Tao, Yingqun ^a   Wei, Qing ^b   Xu, Zaihua ^a   Bai, Rulin ^c   Li, Yao ^b   Luo, Chun ^c   Dong, Yan ^c   Gao, Guoyi ^c   Lu, Yicheng ^c  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b FUDAN UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; COMPLEMENTARY DNA; DEOXYADENOSINE TRIPHOSPHATE; KI 67 ANTIGEN; MYC PROTEIN; PROTEIN MDMX; PROTEIN P53; THIOREDOXIN; TRANSCRIPTION FACTOR FKHRL1; BETA1 INTEGRIN; PROTEOME; TRANSACTIVATOR PROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHILD; CLINICAL RESEARCH; CONTROLLED STUDY; CYCLONE SEPARATOR; DNA DETERMINATION; DNA MICROARRAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; MENINGIOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; PHILOSOPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; SEX DIFFERENCE; TISSUE MICROARRAY; UNINDEXED SEQUENCE; CHEMISTRY; CHINA; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; UPREGULATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD29; CHILD; CHILD, PRESCHOOL; CHINA; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, TAT; HUMANS; IMMUNOBLOTTING; MALE; MENINGIOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; SEX FACTORS; THIOREDOXIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34250336464     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520280307     Document Type: Article

References (52)

1. Y. ADaigo et al., Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3, Cancer Res 59 (1999), 1966-1972.
2. E.Y. Ahn, S.T. Lim, W.J. Cook and J.M. McDonald, Calmodulin binding to the Fas death domain. Regulation by Fas activation, J Biol Chem 279 (2004), 5661-5666.
3. O. Al-Mefty et al., Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings, J Neurosurg 101 (2004), 210-218.
4. O. Al-Mefty, C. Topsakal, S. Pravdenkova, J.R. Sawyer and M.J. Harrison, Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics, J Neurosurg 100 (2004), 1002-1013.
5. T. Andoh, P.B. Chock and C.C. Chiueh, The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells, J Biol Chem 277 (2002), 9655-9660.
6. C.M. Benaud and R.B. Dickson, Regulation of the expression of c-Myc by beta1 integrins in epithelial cells, Oncogene 20 (2001), 759-768.
7. L.M. Butler et al., The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin, Proc Natl Acad Sci USA 99 (2002), 11700-11705.
8. M.J. Calzada et al., Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo, Circ Res 94 (2004), 462-470.
9. N. Cordes, M.A. Blaese, V. Meineke and D. Van Beuningen, Ionizing radiation induces up-regulation of functional beta1-integrin in human lung tumour cell lines in vitro, Int J Radiat Biol 78 (2002), 347-357.
10. A.L. D'Ambrosio and J.N. Bruce, Treatment of meningioma: an update, Curr Neurol Neurosci Rep 3 (2003), 206-214.
11. B. Davidson et al., AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients, Gynecol Oncol 90 (2003), 248-257.
12. M.T. de la Fuente et al., Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine, Biochem Biophys Res Commun 311 (2003), 708-712.
13. M.B. Eisen, P.T. Spellman, P.O. Brown and D. Botstein, Cluster analysis and display of genome-wide expression patterns, Proc Natl Acad Sci USA 95 (1998), 14863-14868.
14. X.H. Feng, Y.Y. Liang, M. Liang, W. Zhai and X. Lin, Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B), Mol Cell 9 (2002), 133-143.
15. E. Izmailova et al., HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages, Nat Med 9 (2003), 191-197.
16. H.G. Jeong et al., Metallothionein-III prevents gamma-ray-induced 8-oxoguanine accumulation in normal and hOGG1-depleted cells, J Biol Chem 279 (2004), 34138-34149.
17. R. Ketter et al., Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases, J-Neurosurg 95 (2001), 601-607.
18. J. Kononen et al., Tissue microarrays for high-throughput molecular profiling of tumor specimen, Nat Med 4 (1998), 844-847.
19. A.E. Konstantinidou et al., Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival, Histopathology 43 (2003), 280-290.
20. A. Korshunov, L. Shishkina and A. Golanov, Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome, Int J Cancer 10 (2003), 728-734.
21. R.M. Lafrenie et al., HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes, J Immunol 157 (1996), 974-977.
22. M.S. Lee, T. Igawa and M.F. Lin, Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells, Oncogene 23 (2004), 3048-3058.
23. S.J. Leu, S.C. Lam and L.F. Lau, Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells, J Biol Chem 277 (2002), 46248-46255.
24. Y. Li et al., Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays, J Cancer Res Clin Oncol 128 (2002), 369-379.
25. D.N. Louis, B.W. Scheithauer, H. Budka, A. von Deimling and J.J.Kepes, Meningiomas, in: Pathology and Genetics of Tumours of the Nervous System: World Health Organisation Classification of Tumours, P. Kleihues, ed., Cavenee WK. (IARC Press, Lyon, France, 2000), pp. 176-184.
26. M. Lovecchio et al., beta 1C Integrin expression in human endometrial proliferative diseases, Am J Pathol 163 (2003), 2543-2553.
27. B. Majello, P. De Luca, G. Hagen, G. Suske and L. Lania, Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1, Nucleic Acids Res 22 (1994), 4914-4921.
28. F. Mancini et al., MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis, J Biol Chem 279 (2004), 8169-8180.
29. A. Martinez-Rumayor et al., Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas, Cancer Lett 213(2004), 117-124.
30. C.P. McArthur, Y. Wang, D. Heruth and S. Gustafson, Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53, Arch Oral Biol 46 (2001), 545-555.
31. A. Menegon, C. Leoni, F. Benfenati and F. Valtorta, Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum, Biochem Biophys Res Commun 238 (1997), 800-805.
32. P. Mezquita, S.S. Parghi, K.A. Brandvold and A. Ruddell, Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation, Oncogene, Epub ahead of print (2004).
33. D. Miyagishi, K. Ohno-Matsui, T. Amagasa and I. Morita, Regulation of the expression of pigment epithelium-derived factor, an anti-angiogenic factor in human oral squamous cell carcinoma cell lines, Cancer Lett 196 (2003), 77-85.
34. H. Miyashita, T. Uchida, S. Mori, S. Echigo and K. Motegi, Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins, Oncol Rep 10 (2003), 1045-1048.
35. K. Okamoto et al., Cyclin G recruits PP2A to dephosphorylate Mdm2, Mol Cell 9 (2002), 761-771.
36. F. Peruzzi, J. Gordon, N. Darbinian and S. Amini, Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway, J Neurovirol 2(Suppl) (2002), 91-96.
37. S.L. Pomeroy et al., Prediction of central nervous system embryonal tumor outcome based on gene expression, Nature 415 (2002), 436-442.
38. R. Ruediger, N. Brewis, K. Ohst and G. Walter, Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production, Virology 238 (1997), 432-443.
39. C.E. Runyan, H.W. Schnaper and A.C. Poncelet, Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells, Am J Physiol Renal Physiol 285 (2003), 413-422.
40. H. Sakurai et al., TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways, Biochem Biophys Res Commun 297 (2002), 1277-1281.
41. J. Seoane, H.V. Le, L. Shen, S.A. Anderson and J. Massague, Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation, Cell 117 (2004), 211-223.
42. D. Sisci et al., Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility, Oncogene 23 (2004), 8920-8930.
43. A. Sunters et al., FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines, J Biol Chem 278 (2003), 49795-49805.
44. C.A. Witz, S. Cho, I.A. Montoya-Rodriguez and R.S. Schenken, The alpha(2)beta(1) and alpha(3)beta(1) integrins do not mediate attachment of endometrial cells to peritoneal mesothelium, Fertil Steril 78 (2002), 796-803.
45. L.R. Whittle et al., Meningiomas, Lancet 363 (2004), 1535-1543.
46. S. Wolfsberger et al., Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature, Neurosurg Rev 27 (2004), 238-245.
47. G. Wrobel et al., Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression, Int J Cancer 2004 Nov 11. [Epub ahead of print].
48. F. Yamasaki et al., Recurrence of meningiomas, Cancer 89 (2000), 1102-1110.
49. H. Zhang et al., Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway, Cancer 95 (2002), 896-906.
50. H. Zhang et al., Mechanism of beta 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2, Hepatology 38 (2003), 305-313.
51. W. Zhu, G.N. Bijur, N.A. Styles and X. Li, Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells, Brain Res Mol Brain Res 126 (2004), 45-56.
52. U. Zimmermann et al., Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination, Cancer Lett 209 (2004), 111-118.